Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasmsLeah Goldberg, Anand Patel, Alexa J. Siddon et al.|Blood Neoplasia|2025Cited by 5
Outcomes of Patients with <i>IDH1/2</i> Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH InhibitorsLeah Goldberg, Anand Patel, James Yoon et al.|Blood|2024Cited by 2